Showing results (161-170 of 253) with videos related to

Sort By:
Pageof 26
Transplantation and Cellular Therapy|June 20, 2025
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative StudyCorrado Tarella, Simona Sammassimo, Samuele Frassoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2017
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantationCarmen Martínez, Jorge Gayoso, Carmen Canals, et al.
Leukemia & Lymphoma|January 7, 2016
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient programPier Luigi Zinzani, Cinzia Pellegrini, Giuseppe Cerciello, et al.
Bone Marrow Transplantation|November 9, 2019
Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemiaMauricette Michallet, Peter Dreger, Mohamad Sobh, et al.
Blood|March 19, 2021
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myelomaAlessandra Larocca, Francesca Bonello, Gianluca Gaidano, et al.
Ejhaem|July 18, 2022
Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphomaVincent Ribrag, Julio C Chavez, Carola Boccomini, et al.
Blood Advances|March 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana LinfomiRexhep Durmo, Stephane Chauvie, Federico Fallanca, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE studyNicole Fabbri, Beatrice Casadei, Annalisa Chiappella, et al.
British Journal of Haematology|December 23, 2024
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE studyFederico Stella, Annalisa Chiappella, Martina Magni, et al.
Haematologica|August 21, 2020
A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphomaEnrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Pageof 26